- Home
- TCBS vs ICCC Comparison
TCBS vs ICCC Comparison
Compare TCBS & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCBS
- ICCC
- Stock Information
- Founded
- TCBS 1934
- ICCC 1982
- Country
- TCBS United States
- ICCC United States
- Employees
- TCBS N/A
- ICCC N/A
- Industry
- TCBS Banks
- ICCC Biotechnology: Pharmaceutical Preparations
- Sector
- TCBS Finance
- ICCC Health Care
- Exchange
- TCBS Nasdaq
- ICCC Nasdaq
- Market Cap
- TCBS 48.7M
- ICCC 55.5M
- IPO Year
- TCBS N/A
- ICCC 1987
- Fundamental
- Price
- TCBS $16.05
- ICCC $6.16
- Analyst Decision
- TCBS
- ICCC
- Analyst Count
- TCBS 0
- ICCC 0
- Target Price
- TCBS N/A
- ICCC N/A
- AVG Volume (30 Days)
- TCBS 2.1K
- ICCC 19.4K
- Earning Date
- TCBS 11-12-2025
- ICCC 11-13-2025
- Dividend Yield
- TCBS 1.00%
- ICCC N/A
- EPS Growth
- TCBS N/A
- ICCC N/A
- EPS
- TCBS 0.80
- ICCC 0.20
- Revenue
- TCBS $14,831,000.00
- ICCC $28,274,756.00
- Revenue This Year
- TCBS N/A
- ICCC N/A
- Revenue Next Year
- TCBS N/A
- ICCC N/A
- P/E Ratio
- TCBS $20.12
- ICCC $31.10
- Revenue Growth
- TCBS 51.57
- ICCC 21.75
- 52 Week Low
- TCBS $14.79
- ICCC $3.38
- 52 Week High
- TCBS $19.40
- ICCC $7.60
- Technical
- Relative Strength Index (RSI)
- TCBS 46.56
- ICCC 46.17
- Support Level
- TCBS $16.10
- ICCC $6.06
- Resistance Level
- TCBS $16.18
- ICCC $6.75
- Average True Range (ATR)
- TCBS 0.09
- ICCC 0.36
- MACD
- TCBS -0.04
- ICCC -0.04
- Stochastic Oscillator
- TCBS 8.95
- ICCC 15.31
About TCBS Texas Community Bancshares Inc.
Texas Community Bancshares Inc is a holding company. The company's business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank of Dallas, in residential real estate loans and commercial real estate loans and, to a lesser extent, commercial loans, construction and land loans, and consumer and other loans. Its portfolio segments are real estate, agriculture, commercial, consumer and other.
About ICCC ImmuCell Corporation
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.